当前位置: 首页» 科研进展» 最新论文

最新论文

Marek's disease virus as a CRISPR/Cas9 delivery system to defend against avian leukosis virus infection in chickens. Vet Microbiol. 2020 Mar;242:108589. doi: 10.1016/j.vetmic.2020.108589.

YongzhenLiu, ZengkunXu, YuZhang, MengmengYu, SuyanWang, YulongGao, ChangjunLiu, YanpingZhang, LiGao, XiaoleQi, HongyuCui, QingPan, ,KaiLi, XiaomeiWang

 

Vet Microbiol. 2020 Mar;242:108589. doi: 10.1016/j.vetmic.2020.108589. Epub 2020 Jan 16.

 

Abstract

The CRISPR/CRISPR-associated protein 9 (Cas9) system is a powerful gene-editing tool originally discovered as an integral mediator of bacterial adaptive immunity. Recently, this technology has been explored for its potential utility in providing new and unique treatments for viral infection. Marek's disease virus (MDV) and avian leukosis virus subgroup J (ALV-J), major immunosuppressive viruses, cause significant economic losses to the chicken industry. Here, we evaluated the efficacy of using MDV as a CRISPR/Cas9-delivery system to directly target and disrupt the reverse-transcribed products of the ALV-J RNA genome during its infection cycle in vitro and in vivo. We first screened multiple potential guide RNA (gRNA) target sites in the ALV-J genome and identified several optimized targets capable of effectively disrupting the latently integrated viral genome and providing efficient defense against new infection by ALV-J in cells. The optimal single-gRNAs and Cas9-expression cassettes were inserted into the genome of an MDV vaccine strain. The results indicated that engineered MDV stably expressing ALV-J-targeting CRISPR/Cas9 efficiently resisted ALV-J challenge in host cells. These findings demonstrated the CRISPR/Cas9 system as an effective treatment strategy against ALV-J infection. Furthermore, the results highlighted the potential of MDV as an effective delivery system for CRISPR/Cas9 in chickens.

Copyright © 2020 Elsevier B.V. All rights reserved.

KEYWORDS:

Avian leukosis virus; CRISPR/Cas9; Infection; Marek’s disease virus

扫一扫 关注我
网站首页 联系我们
TOP